This inventor holds 1 USPTO granted patent. Top assignee: Cytune Pharma. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ulrich Moebius: Inventor in Cancer and Infectious Disease Research.
Introduction
Ulrich Moebius is an inventor associated with Gauting, Germany. His patent work concerns an immune-based approach to treating cancer or infectious diseases.
Latest Patents
The provided information lists one patent for Moebius: “IL-2/IL-15R BETA GAMMA AGONIST DOSING REGIMENS FOR TREATING CANCER OR INFECTIOUS DISEASES.” The patent describes dosing regimens involving an IL-2/IL-15 receptor beta-gamma agonist.
Career Highlights
Moebius is associated with Cytune Pharma. His listed patent reflects work in therapeutic development focused on cancer and infectious diseases. The supplied data does not specify his role at the company or the patent’s filing or grant date.
Collaborations
David Bechard and Irena Adkins are identified as Moebius’s coworkers. The available information does not detail their specific contributions to the patent.
Conclusion
Ulrich Moebius’s listed invention connects his work with Cytune Pharma to immune-based treatment research, with one patent identified in the provided data.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile